About
Research
Patient Care
Education
Community
Wendy Cozen
Delia Tifrea
Experimental Tissue Resource
The Experimental Tissue Resource (ETR) facilitates fresh, frozen, and FFPE human tissue and body fluids procurement and distribution, performs human and animal tissue histology, immunohistochemistry and digital pathology services and performs interpretive histopathology and animal models consultations.
A Marine Bacteria Species Shows Promise for Curing an Aggressive Brain Cancer
Glioblastoma cells are especially adept at dividing quickly; an untreated tumor doubles in size in just two weeks. But that speed comes at a cost, and Bota hoped to take advantage of the cells’ vulnerability. The problem was that none of the available proteasome inhibitors could cross the blood-brain barrier to target glioblastomas where they bloom. Bota, who by then had started her own lab at the University of California, Irvine, found herself thinking about the Nereus presentation.
NIH Diversity Award Supports Loveless’ DNA Recorder to Study Drug Resistance in Breast Cancer Cells
Liu, associate professor of biomedical engineering and director of the Liu Laboratory for Synthetic Evolution where Loveless currently works, said, “Theresa’s research is motivated by a fundamental question in developmental biology: How does a cell’s past experiences shape its present? The K99 award will support Theresa’s development of a new genetic technology that will let us answer that question in vivo.”
John Wayne Cancer Foundation gift establishes new surgical oncology fellowship training program at UCI
A gift from the John Wayne Cancer Foundation will establish the John Wayne Cancer Foundation Endowed Chair in Surgical Oncology and also fund the UCI John Wayne Cancer Foundation Endowed Fellowship in Surgical Oncology at the UCI School of Medicine.
Mentorship, Education and Training Program
The CFCCC Mentorship, Education and Training (MET) Program is a short-term mentoring program designed to build upon the expertise of CFCCC leaders with the goal of supporting junior and mid-career CFCCC faculty (both basic and clinical) and to catalyze strategies to overcoming career and scientific challenges.
Chao Lectureship: Community Lecture 2023
Academic Medicine and Biomedical Innovation at a Crossroads (George Q. Daley, MD, PhD - Harvard Medical School). Reception and Lecture are free to attend. Registration is required (Extended Deadline: Friday, January 27, 2023).
Survivor beats breast cancer, not once but twice
LeeAnn Brill first came to UCI Health in 2015 when she was diagnosed with a rare and aggressive cancer in her right breast. Determined to find the best care and most advanced treatments possible, the registered pharmacist used her considerable research skills.
NPR Academic Minute - "The Central Role of Social Support in the Health of Chinese and Korean American Immigrants"
Immigrants can thrive with a strong support network. Brittany Morey, assistant professor of health, society and behavior, explores why. Brittany N. Morey, PhD, MPH, is an Assistant Professor of Public Health at University of California, Irvine.
NPR Academic Minute - "Follow-Up Care for Young Adult Cancer Survivors"
On University of California, Irvine Week: Lifelong follow up care is critical for young cancer survivors. Joel Milam, professor of epidemiology, examines why. Joel Milam, PhD, is a professor of epidemiology and biostatistics at the University of California, Irvine's Program in Public Health. He also has an adjunct appointment at the UCI School of Medicine's Department of Hematology/Oncology. Dr. Milam's research focuses on young adult cancer survivorship, positive psychology, and HIV prevention/control. Dr. Milam's interest in cancer research led him to become the Co-Leader of the Cancer Control Program at the Chao Family Comprehensive Cancer Center, where he facilitates research to identify and reduce cancer risk, and improve quality of life throughout the cancer care trajectory. Aside from teaching at UCI, Dr. Milam is a Co-Founder & Co-Director of the Center for Young Adult Cancer Survivorship Research. The Center is an interdisciplinary collaborative, including affiliate faculty, trainees, and patient advocates at UCI and USC.
UCI-led study finds psychological therapy reduces biobehavioral impact of testicular cancer
Psychological therapy reduces the adverse biobehavioral effects of testicular cancer in young adult survivors, according to a pilot study led by the University of California, Irvine. Biobehavior is the interaction of biological processes and behavior. Researchers’ findings, published in the American Journal of Men’s Health, show that Goal-focused Emotion-regulation Therapy, developed specifically to enhance the quality of life for these patients, reduced the stress hormone cortisol and the proinflammatory cell protein cytokine IL-1ra that triggers fatigue, pain and other side effects.
Ralph and Sue Stern gift to support cancer center at new UCI hospital in Irvine
UCI Health is pleased to announce a new gift from longtime UCI Health friends Ralph and Sue Stern. In recognition of the family’s latest gift and their lifetime giving of more than $12.5 million to UCI Health, a cancer clinic floor located in the Chao Family Comprehensive Cancer Center and Ambulatory Care building at the UCI Medical Center – Irvine will bear the names of Ralph and Sue Stern.
The UCI Chao Family Comprehensive Cancer Center (CFCCC) is the only National Cancer Institute (NCI)-designated comprehensive cancer center in Orange County.
The UCI Chao Family Comprehensive Cancer Center's mission is to discover, teach and heal within the broad discipline of cancer medicine.
The Chao Family Comprehensive Cancer Center is a national leader in leading-edge research, technology and patient care. Our center is fighting cancer on all fronts through our basic science and clinical research.
Progress comes down to the diagnosis, treatment and survivorship of each patient. This is the calling of the Chao Family Comprehensive Cancer Center (CFCCC): to provide comfort, compassion and, optimistically, a cure during one of the most difficult times of our patients' lives, as they bear the burden of the words, "You have cancer."
Clinical Trials
Clinical trials are research studies to evaluate new drugs or devices aimed to improve treatments and the quality of life of patients. These trials are designed to test novel ways of treating cancer, finding and diagnosing cancer, preventing cancer, and managing side effects and other symptoms due to cancer. Clinical trials are the final step in a long process that begins with research in a lab. Clinical trials are the foundation of cancer screening, treatment and supportive care, allowing patients to receive the newest and most promising therapies.
Comprehensive cancer centers are charged with translating research and providing care to their communities, ensuring that each National Cancer Institute designated center meets the needs of its community.
Stern Center for Cancer Clinical Trials and Research
The Sue and Ralph Stern Center for Cancer Clinical Trials and Research (Stern Center) is the centralized office for cancer clinical research operations at UCI, providing high-quality and efficient support for the development, activation, and completion of scientifically impactful cancer clinical trials.